These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 33705912)

  • 21. A Novel Engineered Small Protein for Positron Emission Tomography Imaging of Human Programmed Death Ligand-1: Validation in Mouse Models and Human Cancer Tissues.
    Natarajan A; Patel CB; Ramakrishnan S; Panesar PS; Long SR; Gambhir SS
    Clin Cancer Res; 2019 Mar; 25(6):1774-1785. PubMed ID: 30373750
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Noninvasive Detection of HER2 Expression in Gastric Cancer by
    Guo X; Zhu H; Zhou N; Chen Z; Liu T; Liu F; Xu X; Jin H; Shen L; Gao J; Yang Z
    Mol Pharm; 2018 Nov; 15(11):5174-5182. PubMed ID: 30251865
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Promising potential of a
    Lv G; Miao Y; Chen Y; Lu C; Wang X; Xie M; Qiu L; Lin J
    Bioorg Chem; 2021 Oct; 115():105294. PubMed ID: 34426150
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preclinical Evaluation of [
    Peng T; Wang X; Li Z; Bi L; Gao J; Yang M; Wang Y; Yao X; Shan H; Jin H
    Mol Pharm; 2021 Sep; 18(9):3638-3648. PubMed ID: 34424706
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Monitoring CD8a
    Kristensen LK; Christensen C; Alfsen MZ; Cold S; Nielsen CH; Kjaer A
    Mol Imaging Biol; 2020 Aug; 22(4):1021-1030. PubMed ID: 32086762
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and evaluation of anti-PD-L1-B11 antibody fragments for PET imaging of PD-L1 in breast cancer and melanoma tumor models.
    Bansal A; Lavoie RR; Lucien F; Kethamreddy M; Wootla B; Dong H; Park SS; Pandey MK
    Sci Rep; 2024 Aug; 14(1):19561. PubMed ID: 39174596
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preparation and Application of a Bioorganic Nanoparticle-Enhanced PDL1-Targeted Small-Molecule Probe.
    Xia L; He C; Guo Y; Meng X; Liu T; Xu X; Guo X; Wang F; Li N; Zhu H; Yang Z
    ACS Appl Mater Interfaces; 2023 Jun; 15(25):30619-30629. PubMed ID: 37310115
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preclinical Study of a Fully Human Anti-PD-L1 Antibody as a Theranostic Agent for Cancer Immunotherapy.
    Xu M; Han Y; Liu G; Xu Y; Duan D; Liu H; Du F; Luo P; Liu Z
    Mol Pharm; 2018 Oct; 15(10):4426-4433. PubMed ID: 30133286
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and preclinical evaluation of a novel molecular probe [
    Sun P; Mo C; Bai L; Wang M; Chen Z; Zhang M; Han Y; Liang H; Tang G
    Bioorg Chem; 2024 Apr; 145():107193. PubMed ID: 38442611
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of PD-L1 Expression in Non-Small Cell Lung Cancers Using [
    Wu Y; Xu D; Gu Y; Li G; Wang H; Cao M; Wei W; Wan P; Guan Y; Chen X; Xie F
    Small Methods; 2024 Jun; ():e2400358. PubMed ID: 38880776
    [TBL] [Abstract][Full Text] [Related]  

  • 31.
    Xiang Q; Li D; Cheng C; Xu K; Zuo C
    Pharmaceuticals (Basel); 2023 Jan; 16(1):. PubMed ID: 36678577
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Application of
    Fan M; Yao J; Zhao Z; Zhang X; Lu J
    Pharmaceuticals (Basel); 2024 Jul; 17(7):. PubMed ID: 39065756
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preclinical development of novel PD-L1 tracers and first-in-human study of [
    Zhang Y; Cao M; Wu Y; Malih S; Xu D; Yang E; Younis MH; Lin W; Zhao H; Wang C; Liu Q; Engle JW; Rasaee MJ; Guan Y; Huang G; Liu J; Cai W; Xie F; Wei W
    J Immunother Cancer; 2024 Apr; 12(4):. PubMed ID: 38580333
    [TBL] [Abstract][Full Text] [Related]  

  • 34. One-step radiosynthesis and initial evaluation of a small molecule PET tracer for PD-L1 imaging.
    Miao Y; Lv G; Chen Y; Qiu L; Xie M; Lin J
    Bioorg Med Chem Lett; 2020 Dec; 30(24):127572. PubMed ID: 32979488
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and comparative evaluation of novel (64)Cu-labeled high affinity cell-specific peptides for positron emission tomography imaging of tumor vasculature.
    Merrill JR; Krajewski K; Yuan H; Frank JE; Lalush DS; Patterson C; Veleva AN
    Biomaterials; 2016 Apr; 84():241-249. PubMed ID: 26839954
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immuno-PET imaging of
    Liu Q; Jiang L; Li K; Li H; Lv G; Lin J; Qiu L
    Cancer Immunol Immunother; 2021 Jun; 70(6):1721-1733. PubMed ID: 33386467
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and biological evaluation of Al[
    Sun P; Han Y; Hu K; Huang S; Wang M; Zhou K; Fu L; Chen H; Tang G
    Bioorg Chem; 2022 May; 122():105682. PubMed ID: 35278777
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    Bridgwater C; Geller A; Hu X; Burlison JA; Zhang HG; Yan J; Guo H
    Cancer Biother Radiopharm; 2020 Oct; 35(8):549-557. PubMed ID: 32315549
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting Phosphatidylserine with a
    Perreault A; Richter S; Bergman C; Wuest M; Wuest F
    Mol Pharm; 2016 Oct; 13(10):3564-3577. PubMed ID: 27608290
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and Biologic Evaluation of a Novel
    Donnelly DJ; Smith RA; Morin P; Lipovšek D; Gokemeijer J; Cohen D; Lafont V; Tran T; Cole EL; Wright M; Kim J; Pena A; Kukral D; Dischino DD; Chow P; Gan J; Adelakun O; Wang XT; Cao K; Leung D; Bonacorsi SJ; Hayes W
    J Nucl Med; 2018 Mar; 59(3):529-535. PubMed ID: 29025984
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.